**Job Description**
The Rosenfeld lab at the Barts Cancer Institute, Queen Mary University of London, is seeking an outstanding lab-based molecular biologist to play a key role in developing and deploying cutting-edge next-generation sequencing assays for earlier cancer detection. The role involves contributing to minimally-invasive molecular diagnostics and analysis of cancer genomes, specifically utilizing next-generation sequencing of circulating cell-free tumour DNA (ctDNA). The successful candidate will contribute to developing novel tools for cancer diagnostics, demonstrating clinical utility, and exploring the biophysical properties of ctDNA.
**Skills & Abilities**
• Experience in development and application of next-generation sequencing assays.
• Experience of translational research using human samples (distinct advantage).
• Experience in development of clinical diagnostic assays (distinct advantage).
• Experience in bioinformatic analysis of next-generation sequencing data (distinct advantage).
• Highly motivated.
• Detail-oriented.
• Excellent communication skills.
• Well organised.
• Able to work independently.
• Able to interact effectively in a multi-disciplinary team environment.
**Qualifications**
Required Degree(s) in:
• Ph.D (or about to receive)
**Experience**
Other:
• Experience in development and application of next-generation sequencing assays.
• Experience with samples related to Melanoma and Head & Neck cancer diagnostics (preferred).
• Experience of translational research using human samples (advantageous).
• Experience in development of clinical diagnostic assays (advantageous).
• Experience in bioinformatic analysis of next-generation sequencing data (advantageous).
Note: We’ve analyzed the actual job post using AI, for more details visit the original job post by clicking on “Apply Now”!
